Author: Phil McCracken

Phil McCracken covers Washington from the stress fracture outward. His reporting studies the crack between public virtue and private invoicing, where patriotic speeches, donor checks, midnight amendments, and think-tank PDFs all meet for drinks and pretend it is civic duty. McCracken follows the money, the lobbyists, the favors, the sudden changes of heart, and the miraculous policy positions that bloom shortly after a fundraiser. He is less impressed by flag pins than by loopholes, delays, carve-outs, and the small-print blessings that make corruption look like procedure. His beat is rot in the broad civic sense: not just crime, but structure; not just scandal, but design; not just who got caught, but who built the room where getting caught barely matters. He cracks the door open and lets the fluorescent shame leak out. Categories: Politics, Corruption, Justice, Business, U.S.
  • |

    Pentagon’s $350 Million Contract Trail Raises Questions About Old Ties

    ByPhil McCracken

    The awards and the question

    The Pentagon’s contract paperwork has produced a familiar Washington puzzle: substantial public spending, a flexible procurement route, and a reported business connection that deserves a closer look without being mistaken for proof of misconduct. ProPublica reported that Alvarez & Marsal Federal received a $281 million no-bid Pentagon consulting contract; altogether, Alvarez & Marsal-related entities received nearly $350 million in military spending across two deals since December. The question is not whether a connection automatically proves a conflict. It does not. The question is whether the decisions, disclosures, and oversight are clear enough for the public to follow the money.

    Separate companies, relevant questions

    ProPublica’s investigation also reported that George Kollitides had an advisory connection to A&M Capital when the contracts were signed. That relationship is relevant context, but it is not evidence that Kollitides directed or influenced the awards, or personally benefited from them. Nor should Alvarez & Marsal Federal, the consulting business, and A&M Capital be collapsed into one convenient corporate blob. In procurement, names and relationships matter; so do the distinctions between them. The public deserves a map, not a fog machine.

    What the procurement route means

    The $281 million consulting award used an other transaction agreement, or OTA. The Government Accountability Office says OTAs can give the Defense Department flexibility to work with industry, but its broader review also identifies oversight risks, including less visibility into contractor costs. That is general context, not a GAO finding about these specific awards. Still, flexibility is not a magic word that makes scrutiny unnecessary. When a large contract uses a route with different oversight features, taxpayers have a reasonable interest in how the department tested costs and documented its decision.

    What officials say—and what remains

    The Pentagon told ProPublica that applicable ethics rules were followed. A&M Capital said it is separately managed from the consulting business. Those responses matter, and they should be included alongside the reporting. They do not, on their own, answer every public question about how the awards were evaluated, what disclosures decision-makers made, or what records support the department’s process. The reporting does not establish wrongdoing, and the available facts should not be stretched into an accusation. But “rules were followed” is a conclusion; accountability also depends on whether the underlying process can be examined.

    Follow the invoice

    Defense spending is not an abstract line in a spreadsheet. It is public money assigned to work the government says it needs, and the public should be able to understand why a contractor was selected and how the bill will be watched. A reported relationship is not a verdict. An OTA is not evidence of abuse. Together with a large award, however, they make disclosure and oversight ordinary questions—not hostile ones. Washington has never lacked confidence in its own paperwork. The useful test is whether the paperwork lets everyone else see who made the call, on what basis, and how the public gets its money’s worth.

  • |

    Freedom 250’s public bill—and the private donations still outside the ledger

    ByPhil McCracken

    Freedom 250’s newly released budget estimate puts key event costs at $128.5 million and anticipated federal funding at $114.2 million. The narrow question in the paperwork is how the private money reportedly raised for the effort is reflected. The estimate does not appear to show how those donations were allocated to the events. That is a transparency gap worth tracking—not evidence, by itself, that anyone mishandled funds.

    What the records show

    On October 8, the watchdog group Public Employees for Environmental Responsibility (PEER) released records it obtained through a public-records request. The budget estimate lists $128.5 million in projected costs and $114.2 million in anticipated federal funding. The record packet also includes a procurement-waiver request and a National Park Service cooperative agreement, pieces of the federal arrangement behind the events. They help explain the public side of the financing; they are not a final, all-in accounting.

    An estimate is a planning document, not a paid invoice. PEER has raised questions about the contracting and taxpayer-funding arrangements, but those questions should not be upgraded into findings the documents do not establish. A waiver request is not, on its own, proof of improper contracting. Bureaucratic paperwork can be alarming without becoming a verdict. The money trail deserves scrutiny; it also deserves accurate labels.

    The private-money question

    The Washington Sun reported that earlier disclosures showed more than $50 million in private funds had been raised for Freedom 250. The outlet said the released estimate did not appear to assign those donations to the events. From this estimate alone, readers cannot see how the reported private funds fit alongside anticipated federal funding and projected costs. It does not show that donations are missing, diverted, or unlawfully handled. A ledger with an unanswered column is an unanswered question—not a crime scene.

    The Washington Sun reported that the administration disputed or qualified treating the estimate as final, and that costs were still being reconciled. So the $128.5 million figure should not be presented as the final cost, and the current documents should not be mistaken for a complete accounting. Reconciliation is part of settling expenses; it is also why the final version matters. Until the accounts are brought together, the estimate does not show how the private and federal funding streams relate.

    What a final accounting should clarify

    A clear final accounting would show total costs, funding sources, and how private donations were allocated, while distinguishing commitments from money actually spent. That would let taxpayers and donors follow the basic trail: what came in, what went out, and which expenses each source covered. For now, the released records offer meaningful figures and a limited view of the arrangement. The right conclusion is neither “nothing to see” nor “case closed.” It is simpler: publish the reconciled accounting, then let the numbers do their job.

  • |

    Pittsburgh’s Sole-Source Shortcut Has an Audit Trail

    ByPhil McCracken

    I’m Phil McCracken, and “sole source” is the kind of phrase that should make every taxpayer ask two questions: who got access, and who got the bill? A Pittsburgh search-warrant affidavit unsealed September 21 has raised questions about how public contracting safeguards were used. Local reporting says the affidavit alleges no-bid contracts and political ties. Those are allegations, not established findings, and the distinction matters as much as the invoice.

    Competitive bidding is not paperwork for paperwork’s sake. It is supposed to give the public a way to see how vendors were considered, why one was selected, and whether the price and process can stand in daylight. When that process is bypassed, or appears to have been, the public loses more than a chance to compare bids. It loses the ordinary trail that lets residents understand how decisions were made with their money.

    Public Source’s coverage of the affidavit explicitly notes that the claims had not been proven and that no one had been charged in connection with the investigation at publication. The Pittsburgh Post-Gazette also reported on the warrant and the allegations described in the affidavit. That is the boundary here: reporting about an investigation is not a verdict, and political ties are not proof of a contract-for-support exchange. The investigation was reported as ongoing; the allegations still have to be tested.

    That caution does not make the questions irrelevant. It makes a clear public accounting more important. If safeguards worked, records should help show how. If they did not, the public deserves to know where the process broke down and what controls are supposed to prevent a repeat. Taxpayers should not have to guess whether a vendor earned a contract through open competition or entered through a side door nobody can explain.

    In procurement, “sole source” may describe a contracting route. For the public, it should mean something else: one clear source for where the money went. Pittsburgh residents should not need a search-warrant affidavit to follow their own dollars. The money trail ought to be visible before investigators have to put on their shoes.

  • |

    Two PACs, One Treasurer, Zero New Ideas

    ByPhil McCracken

    The money trail wore cologne and arrived carrying two name tags. No Going Back PAC and Safety and Affordability PAC were both formed on September 1, according to reporting from Bloomberg Law and the Associated Press. Both reportedly list the same treasurer as MAGA Inc. That does not make them the same legal entity, and it does not by itself prove illegal coordination. It does, however, give voters the political equivalent of two restaurants sharing a kitchen, a cash register, and the same guy shouting today’s specials.

    Bloomberg Law also reported that the committees share banks and addresses, while the AP described their connections to the broader Trump-aligned network. Their advertising reservations and spending are reported at more than $130 million by the AP and roughly $140 million by Bloomberg Law. That is a lot of money to spend telling the public that every wallet has its own personality. One committee can be the rugged patriot, the other can be the responsible neighbor, and both can apparently send the invoice to the same back office.

    This is the campaign-finance system’s favorite magic trick: confuse formal separation with practical independence. The paperwork can provide distinct names, distinct branding, and enough administrative furniture to satisfy the filing cabinet. Meanwhile, ordinary people are left decoding who is actually behind the message while the message is already occupying every commercial break between weather, sports, and a pharmaceutical ad warning that breathing may cause complications.

    That is the contradiction worth following. Separate PAC names may be perfectly lawful, but they can still create the appearance of several independent political voices when the money-and-management plumbing points toward one familiar operation. Transparency becomes less a window than a scavenger hunt, with voters expected to inspect treasurers, addresses, banks, affiliations, and advertising reservations after the political sales pitch has already made itself comfortable.

    Washington has apparently discovered camouflage for money: give the operation two names, a fresh address line, and enough advertising to make disclosure arrive after the commercial break. The PAC ate the receipt, and the public is left holding the menu.

  • |

    The Midterms Have a New Department of Emergency Billionaire Spending

    ByPhil McCracken

    The campaign wants to look like a people-powered movement, but the emergency package is arriving from a PAC-connected donor network. The Associated Press reports that Trump-aligned groups have reserved more than $130 million in advertising for vulnerable Republican races, including $27 million from the Safety and Affordability PAC. That PAC was formed September 1 and is connected to MAGA Inc. Follow the invoice and the grassroots suddenly has a national media department.

    This is campaign triage: political first responders rushing in whenever public enthusiasm needs private life support. Nobody is claiming the advertising guarantees victory or proves illegal coordination. The narrower point is more useful. Voters are being asked to read an outside advertising reserve as evidence of organic momentum, when the disclosed numbers show a donor-funded rescue operation working behind the slogan.

    The Federal Election Commission’s reporting calendar provides the plumbing for this disclosure. PACs and political parties have scheduled reporting obligations, which is how the public gets to see the money trail instead of merely smelling donor perfume in a television commercial. A September 1-created PAC committing $27 million to advertising is not a neighborhood bake sale with better signage. It is a national financial instrument wearing a local campaign button.

    That gap matters because candidates are marketed as locally grown products while arriving with a donor-funded warranty. The public is told the movement is broad, spontaneous, and powered by regular people. Then an outside group connected to MAGA Inc. reserves tens of millions in airtime to protect candidates whose support apparently requires an emergency broadcast system. The people paying for democracy deserve to know who is underwriting the sales pitch and why the rescue crew keeps getting called.

    Welcome to the Department of Emergency Billionaire Spending, where every vulnerable candidate receives a complimentary media ambulance and every advertisement arrives with a patriotic siren. Congress is still for sale, but now the purchase order is marked urgent. The voters are treated as the crisis, while wealthy networks get to invoice themselves as the response team.

  • |

    NVIDIA Got the Chip, Taxpayers Got the Receipt

    ByPhil McCracken

    I opened the taxpayer invoice and found the usual public-private magic trick: grants, university science, and open research absorb the early risk, then NVIDIA turns the broader foundation into products while the public contribution vanishes from the paperwork. To be clear, that does not mean NVIDIA did nothing or that taxpayers legally own the company. It means the money trail deserves more than a ceremonial thank-you card.

    At the public invoice desk, the down payment is stamped complimentary, while the private payoff arrives with enough zeros to require its own zip code. Fair taxes, public reinvestment, or public-interest conditions are not radical demands when shared science helps make extraordinary fortunes possible. Follow the invoice and ask the plain question: if the public helped build the future, why is its return always listed as “pending”?

  • |

    Meta’s $26 Million Invoice Comes With an $8 Billion Punchline

    ByPhil McCracken

    I followed the invoice, and it led straight to Washington’s premium lounge: a depicted $26 million in Meta payments connected to Trump beside a claimed $8 billion tax break. The numbers are presented as roughly 308 times back, which is a remarkable return unless your definition of public service includes handing out loyalty points near presidential power. The accusation is not proof of a deal, but it is a sharp question: why does political access so often look like an investment strategy?

    That is the part taxpayers should not have to shrug away. Corporations can pursue influence, benefits, and friendly policy; ordinary people absorb the uncertainty when public decisions start resembling private rewards. If the money trail is wearing cologne, someone should still check the receipt. In Washington, the powerful collect points for proximity while everyone else gets stuck paying for the program.

  • |

    Public Cancer Research, Private Cancer Profits: The Taxpayer Paid Twice

    ByPhil McCracken

    I followed the Taxol invoice, and the handwriting gets suspiciously fancy near the bottom. Publicly supported NIH research helped carry the scientific risk behind paclitaxel, while Bristol Myers Squibb became the name attached to the commercial blockbuster. The exact accounting deserves careful checking, but the central complaint is hard to miss: shared research can become private revenue before the public gets a meaningful return.

    That is the pharmaceutical business model in a lab coat. Taxpayers help finance the runway, private interests get the applause, and patients are handed the receipt for progress they helped make possible. Nobody objects to a company earning money by bringing a treatment to patients; the question is why public investment so often exits through the front door while public accountability is left waiting in the lobby. Follow the invoice long enough and “research for all” can end with profits for the private and a second bill for the sick.

  • |

    Cornhusker Majority Arrives With a $1.4 Million Nebraska Ad Receipt

    ByPhil McCracken

    Nebraska is apparently the political equivalent of a locked pantry: safe, quiet, and not expected to require emergency supplies. Then Cornhusker Majority showed up with a reported $1.4 million advertising invoice to protect Sen. Pete Ricketts. That does not prove the Senate seat has become a Democratic takeover project. It does prove somebody saw enough risk—or enough billable opportunity—to start buying political insurance.

    Axios reported on September 15 that the newly formed Republican-linked super PAC would begin airing its ads September 16. The group appears connected to the Senate Leadership Fund, though that is not the same as saying the fund formally controls it. The distinction matters. In campaign finance, “connected to” is often where the money trail puts on a clean shirt and asks everyone to admire the paperwork.

    The other part of the receipt is even more revealing: Axios reported that the National Republican Senatorial Committee did not appear to be spending in Nebraska. So the race is being treated as low priority in the public conversation, while a separate GOP-aligned operation steps in with seven figures to keep the supposedly safe seat comfortably safe. That is not necessarily a contradiction in electoral math. It is a contradiction in political salesmanship.

    Safe seats need no rescue until consultants discover a reason to sell protection. Then the quiet state becomes a premium market, the routine defense becomes an urgent media buy, and the invoice acquires the emotional intensity of a five-alarm fire. Voters are left watching the same old transaction: public confidence on the front end, private anxiety billing on the back.

    Follow the invoice and the point gets plain. Cornhusker Majority’s reported buy is not evidence that Nebraska has suddenly become a national battleground; it is evidence that “safe” can mean “safe, provided somebody keeps paying.” The Corn Belt remains secure right up until a consultant opens the door, smells a competitive pulse, and discovers another reason to send the bill.

    Sources

  • |

    The Drug Pricing Rule Has a Lobbyist in the Back Seat

    ByPhil McCracken

    I look at Washington’s healthcare paperwork the way a diner waitress looks at a fake coupon: polite, tired, and already hunting for the fine print. CMS is considering a proposed Medicare rule that could treat certain fixed-combination drugs as the same qualifying single-source drug as an originator medicine for price negotiation. Patients may see one prescription. The policy question is whether Washington sees one product—or several convenient identities parked under the same hood.

    CMS issued the proposal June 12, set an August 17 comment deadline, and is expected to finalize it in fall 2026. That makes this less a chemistry quiz than a money-trail dispute. If a combination product remains legally separate from the medicine it combines, more revenue could remain outside the negotiation process. That is not proof anyone designed the product as an escape hatch. It is the practical question sitting on the counter while everyone argues about labels.

    Inside Health Policy reported that biologics manufacturers objected to CMS’s approach, arguing that separate FDA categories raise legal-authority and innovation concerns. Those are serious arguments, and agencies should not smuggle major policy changes through a filing cabinet labeled “technical clarification.” But the industry’s preferred separation also has a financial consequence: separate categories can mean separate treatment when Medicare decides what qualifies for negotiation.

    This is where the fine print starts wearing donor perfume. The public argument is about innovation, regulatory boundaries, and whether CMS has gone too far. The money question is simpler: who benefits if the category stays split? Manufacturers may preserve separate revenue streams from negotiated pricing, while patients and taxpayers are left to admire the elegance of the classification system from the payment window.

    At the pharmacy drive-through, nobody orders “one originator medicine with a regulatory garnish.” They get a prescription. In Washington, however, one prescription can be asked to produce two billing identities, two receipts, and two opportunities to keep the negotiated-price window closed. The rule is still proposed, the dispute is still active, and the invoice has not finished crawling out from under the lobbyist’s coat. But the public should know what this technical fight can decide: whether a medicine’s category serves patients—or protects the revenue attached to it.

    Sources

End of content

End of content